|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-4-10
|
|
pubmed:abstractText |
Experimental data suggest that levosimendan has pulmonary vasodilatory properties which, in combination with its positive inotropic effects, would render it particularly attractive for the treatment of right ventricular dysfunction. To test this hypothesis, we developed an experimental model of right ventricular failure and analyzed the effects of levosimendan on ventriculovascular coupling between the right ventricle and pulmonary artery (PA).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0090-3493
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
707-15
|
|
pubmed:dateRevised |
2007-9-13
|
|
pubmed:meshHeading |
pubmed-meshheading:17255859-Animals,
pubmed-meshheading:17255859-Cardiotonic Agents,
pubmed-meshheading:17255859-Disease Models, Animal,
pubmed-meshheading:17255859-Hydrazones,
pubmed-meshheading:17255859-Hypertension, Pulmonary,
pubmed-meshheading:17255859-Myocardial Contraction,
pubmed-meshheading:17255859-Pulmonary Artery,
pubmed-meshheading:17255859-Pyridazines,
pubmed-meshheading:17255859-Stroke Volume,
pubmed-meshheading:17255859-Swine,
pubmed-meshheading:17255859-Vascular Resistance,
pubmed-meshheading:17255859-Vasodilator Agents,
pubmed-meshheading:17255859-Ventricular Dysfunction, Right,
pubmed-meshheading:17255859-Ventricular Function, Right
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
|
|
pubmed:affiliation |
Center for Experimental Anesthesiology, Emergency and Intensive Care Medicine, Department of Acute Medical Sciences, Katholieke Universiteit Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
